The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 12 Feb 2008
doi: 10.1242/jcs.025312
Research Article
Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1
Ciaran Richardson*,
Fatema H. Rafiqi,
Håkan K.R. Karlsson,
Ntsane Moleleki,
Alain Vandewalle,
David G. Campbell,
Nick A. Morrice,
and
Dario R. Alessi
* Author for correspondence (e-mail: c.j.z.richardson{at}dundee.ac.uk)
Mutations increasing WNK1 kinase expression in humans cause the pseudohypoaldosteronism type II hypertension syndrome. This condition is treated effectively by thiazide diuretics, which exert their effects by inhibiting the Na+-Cl- cotransporter (NCC), suggesting a link between WNK1 and NCC. Here, we demonstrate that the SPAK and OSR1 kinases that are activated by WNK1 phosphorylate human NCC at three conserved residues (Thr46, Thr55 and Thr60). Activation of the WNK1-SPAK/OSR1 signalling pathway by treatment of HEK293 or mpkDCT kidney distal-convoluted-tubule-derived cells with hypotonic low-chloride conditions induced phosphorylation of NCC at residues phosphorylated by SPAK/OSR1. Efficient phosphorylation of NCC was dependent upon a docking interaction between an RFXI motif in NCC and SPAK/OSR1. Mutation of Thr60 to Ala in NCC markedly inhibited phosphorylation of Thr46 and Thr55 as well as NCC activation induced by hypotonic low-chloride treatment of HEK293 cells. Our results establish that the WNK1-SPAK/OSR1 signalling pathway plays a key role in controlling the phosphorylation and activity of NCC. They also suggest a mechanism by which increased WNK1 overexpression could lead to hypertension and that inhibitors of SPAK/OSR1 might be of use in reducing blood pressure by suppressing phosphorylation and hence activity of NCC.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Ohta, T. Rai, N. Yui, M. Chiga, S.-S. Yang, S.-H. Lin, E. Sohara, S. Sasaki, and S. Uchida
Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure
Hum. Mol. Genet.,
October 15, 2009;
18(20):
3978 - 3986.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Gamba
The thiazide-sensitive Na+-Cl- cotransporter: molecular biology, functional properties, and regulation by WNKs
Am J Physiol Renal Physiol,
October 1, 2009;
297(4):
F838 - F848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Vallon, J. Schroth, F. Lang, D. Kuhl, and S. Uchida
Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1
Am J Physiol Renal Physiol,
September 1, 2009;
297(3):
F704 - F712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Zhang, X. Xu, Y. Zhang, J. Zhou, Z. Yu, and C. He
LINGO-1 Interacts with WNK1 to Regulate Nogo-induced Inhibition of Neurite Extension
J. Biol. Chem.,
June 5, 2009;
284(23):
15717 - 15728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Glover, A. M. Zuber, and K. M. O'Shaughnessy
Renal and Brain Isoforms of WNK3 Have Opposite Effects on NCCT Expression
J. Am. Soc. Nephrol.,
June 1, 2009;
20(6):
1314 - 1322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. San-Cristobal, D. Pacheco-Alvarez, C. Richardson, A. M. Ring, N. Vazquez, F. H. Rafiqi, D. Chari, K. T. Kahle, Q. Leng, N. A. Bobadilla, et al.
Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway
PNAS,
March 17, 2009;
106(11):
4384 - 4389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Richardson and D. R. Alessi
The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway
J. Cell Sci.,
October 15, 2008;
121(20):
3293 - 3304.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2008
